Ignite Creation Date:
2025-12-24 @ 5:13 PM
Ignite Modification Date:
2026-02-13 @ 11:06 AM
Study NCT ID:
NCT01114750
Status:
SUSPENDED
Last Update Posted:
2010-10-05
First Post:
2010-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)
Sponsor:
Bows Pharmaceuticals AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2010-10
Completion Date Type:
ESTIMATED
First Submit Date:
2010-04-29
First Submit QC Date:
None
Study First Post Date:
2010-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-10-03
Last Update Post Date:
2010-10-05
Last Update Post Date Type:
ESTIMATED